User profiles for Stanley Fahn

Stanley Fahn

Columbia University
Verified email at columbia.edu
Cited by 19226

Description of Parkinson's disease as a clinical syndrome

S Fahn - Annals of the New York Academy of Sciences, 2003 - Wiley Online Library
Parkinsonism is a clinical syndrome comprising combinations of motor problems—namely,
bradykinesia, resting tremor, rigidity, flexed posture, “freezing,” and loss of postural reflexes. …

[PDF][PDF] Clinical rating scale for tremor

S Fahn, E Tolosa, C Marín - Parkinson's disease and movement …, 1993 - researchgate.net
The word tremor is derived from the Latin tremere, meaning “to tremble.” Tremor can be
defined as involuntary oscillations of any part of the body around any plane, such oscillations …

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

…, JQ Trojanowski, D Eidelberg, S Fahn - … England Journal of …, 2001 - Mass Medical Soc
Background Transplantation of human embryonic dopamine neurons into the brains of patients
with Parkinson's disease has proved beneficial in open clinical trials. However, whether …

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

S Fahn, G Cohen - Annals of neurology, 1992 - Wiley Online Library
Oxidant stress, due to the formation of hydrogen peroxide and oxygen‐derived free radicals,
can cause cell damage due to chain reactions of membrane lipid peroxidation. Because the …

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results

…, SR Shaftman, GT Stebbins, S Fahn… - … : official journal of the …, 2008 - Wiley Online Library
We present a clinimetric assessment of the Movement Disorder Society (MDS)‐sponsored
revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS). The MDS‐UDPRS …

Neurodegeneration and neuroprotection in Parkinson disease

S Fahn, D Sulzer - NeuroRx, 2004 - Elsevier
Many of the motoric features that define Parkinson disease (PD) result primarily from the
loss of the neuromelanin (NM)-containing dopamine (DA) neurons of the substantia nigra (SN), …

Does levodopa slow or hasten the rate of progression of Parkinson's disease?

S Fahn, Parkinson Study Group - Journal of neurology, 2005 - Springer
Levodopa therapy, as originally established by George Cotzias [2, 3], is the most powerful
treatment for Parkinson’s disease (PD). Levodopa’s toxicity to neurons in vitro has raised …

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

…, J Trojanowski, H Basun, L Lannfelt, M Neystat, S Fahn… - Nature, 1998 - nature.com
Thirteen families have been described with an autosomal dominantly inherited dementia
named frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) 1 , 2 , 3 …

Phenomenology and classification of dystonia: a consensus update

…, SB Bressman, MR DeLong, S Fahn… - Movement …, 2013 - Wiley Online Library
This report describes the consensus outcome of an international panel consisting of investigators
with years of experience in this field that reviewed the definition and classification of …

[HTML][HTML] Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease

…, EV De Marco, A Dürr, MJ Eblan, S Fahn… - … England Journal of …, 2009 - Mass Medical Soc
Background Recent studies indicate an increased frequency of mutations in the gene
encoding glucocerebrosidase (GBA), a deficiency of which causes Gaucher's disease, among …